Tagliabue A, Nencioni L, Caffarena A, Villa L, Boraschi D, Cazzola G, Cavalieri S
Clin Exp Immunol. 1985 Nov;62(2):242-7.
Seventeen adult volunteers were vaccinated orally with the live attenuated Salmonella typhi mutant strain Ty21a. Their peripheral blood mononuclear cells were tested at different times after vaccination for direct cell-mediated activity against bacteria, employing a simple short-term in vitro assay. It was observed that 16/17 of the vaccinated subjects acquired the capacity to express specific cellular immunity against S. typhi which lasted from 15 days to at least 3 years. The effector cell of the in vitro antibacterial activity was preliminarily characterized as a non-adherent T3+, T8-, T4+ lymphocyte. In parallel, mice immunized orally with S. typhimurium and proving resistant to reinfection were tested employing the same in vitro assay. Also in this case peripheral and, most important, intestinal lymphocytes were able to express cellular immunity against the agent of murine typhoid. It is concluded that administration of live oral vaccine against S. typhi results in the induction of specific cellular immunity which is expressed at the peripheral and, probably, also at the intestinal level.
17名成年志愿者口服了减毒活伤寒沙门氏菌突变株Ty21a。接种疫苗后,在不同时间对他们的外周血单核细胞进行检测,采用一种简单的短期体外试验来检测其针对细菌的直接细胞介导活性。观察到16/17的接种受试者获得了表达针对伤寒沙门氏菌的特异性细胞免疫的能力,这种免疫持续了15天至至少3年。体外抗菌活性的效应细胞初步被鉴定为非黏附性T3 +、T8 -、T4 +淋巴细胞。同时,用鼠伤寒沙门氏菌口服免疫并证明对再感染有抵抗力的小鼠也采用相同的体外试验进行检测。同样在这种情况下,外周淋巴细胞,最重要的是肠道淋巴细胞能够表达针对鼠伤寒病原体的细胞免疫。得出的结论是,口服伤寒沙门氏菌活疫苗可诱导特异性细胞免疫,这种免疫在外周以及可能在肠道水平表达。